3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Recruiting
2
Unknown
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
25
Gastrointestinal
14
Other hematologic neoplasm
13
Head & Neck
5
Thoracic
4
Lymphoid
4
Sarcoma
3
Plasma cell
3
Gynecologic
3
Classical hematology
3
Myeloid
2
Other neoplasm
1
Genitourinary
1
Dermatologic
1
Conditions
Sarcoma
1336
Glioblastoma
493
Gliosarcoma
470
Osteosarcoma
363
Brain Neoplasms
321
Central Nervous System Neoplasms
276
Astrocytoma
262
Dendritic Cell Sarcoma, Interdigitating
258
Gastrointestinal Stromal Tumors
251
Neoplasms
231
Glioma
229
Lymphoma
226
Neuroblastoma
209
Rhabdomyosarcoma
208
Breast Neoplasms
204
Sarcoma, Ewing
202
Recurrence
202
Burkitt Lymphoma
198
Lymphoma, Non-Hodgkin
196
Precursor Cell Lymphoblastic Leukemia-Lymphoma
195
Oligodendroglioma
192
Melanoma
182
Ovarian Neoplasms
175
Lymphoma, Large B-Cell, Diffuse
173
Neoplasm Metastasis
172
Bone Neoplasms
168
Lymphoma, Follicular
158
Leukemia, Lymphocytic, Chronic, B-Cell
144
Lymphoma, Mantle-Cell
143
Liposarcoma
143
Interventions
Standard of Care
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
sarilumab
1
regorafenib
1
pexidartinib
1
pertuzumab
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
durvalumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
Transurethral Resection of Bladder
1
STA 9090
1
SGN-LIV1A
1
Paclitaxel
1
MK 2206
1
Letrozole
1
Lasofoxifene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Interventional
×
Pathologic Complete Response
×
Sarcoma
×
Clear all
NCT01042379
2026-05-06
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2
Recruiting
5,000 enrolled
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled
NCT05684874
2023-10-30
SarQuantIRM
Centre Leon Berard
Phase NA
Unknown
25 enrolled